TrialThe Journal of infectious diseases2019

Tenofovir Gel for Prevention of Herpes Simplex Virus Type 2 Acquisition: Findings From the VOICE Trial.

Jeanne M Marrazzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.